Literature DB >> 8286516

Fish oil increases the release of tumour necrosis factor and interleukin-6, and has no effect on the incidence of multiple organ failure in rats with peritonitis.

C Rosman1, J Grond, W A Buurman, B J de Smet, R de Jonge, M Sietsma, R van Schilfgaarde, R P Bleichrodt.   

Abstract

OBJECTIVE: To find out if fish oil given intraperitoneally would cause a reduction in the release of tumour necrosis factor and interleukin-6 in abdominal exudate and blood (experiment A), and if it reduces the incidence of organ failure in rats with peritonitis (experiment B).
DESIGN: Laboratory experiment.
SETTING: University animal laboratory. MATERIAL: Thirty-six selectively decontaminated rats in each experiment.
INTERVENTIONS: All rats were pretreated with 2 ml fish oil, lecithin, or saline, intraperitoneally for one or six weeks before intraperitoneal injection of zymosan. Experiment A: Samples of abdominal exudate and plasma were taken regularly for 24 hours after the zymosan had been given. Experiment B: Clinical, biochemical, and histological variables were measured over a 12-day period after the zymosan had been given. MAIN OUTCOME MEASURES: Experiment A: Concentrations of tumour necrosis factor and interleukin-6 in abdominal exudate and plasma. Experiment B: Incidence of multiple organ failure.
RESULTS: Experiment A: Concentrations of tumour necrosis factor and interleukin-6 in abdominal exudate and plasma were significantly higher in rats pretreated with fish oil, compared with control rats. This effect was more pronounced after six weeks of pretreatment. Experiment B: There were no significant differences between the groups for any variable.
CONCLUSION: Fish oil given intraperitoneally increased rather than reduced local and systemic release of tumour necrosis factor and interleukin-6, and did not reduce the incidence of organ failure in rats with sterile peritonitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8286516

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  1 in total

1.  Procalcitonin (PCT) in patients with abdominal sepsis.

Authors:  H B Reith; U Mittelkötter; R Wagner; A Thiede
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.